| Title | Author(s) | Year | View Count |
 | Genome-wide association study identifies a susceptibility locus for thyrotoxic periodic paralysis at 17q24.3 | Cheung, CL; Lau, KS; Ho, AYY; Lee, KK; Tiu, SC; Lau, EYF; Leung, J; Tsang, MW; Chan, KW; Yeung, CY; Woo, YC; Cheung, EYN; Hung, VHF; Pang, HK; Hung, CS; Sham, PC; Kung, AWC | 2012 | 50 |
| Genetic and clinical characteristics of maturity-onset diabetes of the young in Chinese patients | Xu, JY; Dan, QH; Chan, V; Wat, NMS; Tam, S; Tiu, SC; Lee, KF; Siu, SC; Tsang, MW; Fung, LM; Chan, KW; Lam, KSL | 2005 | 116 |
| Resistance to thyroid hormone in a Chinese family with R429Q mutation in the thyroid hormone receptor beta gene | Kong, APS; Lam, CW; Chan, AOK; Yiu, SF; Tiu, SC | 2005 | 70 |
| Normal cord blood thyroid-stimulating hormone in a child with resistance to thyroid hormone | Chan, AOK; Lam, CW; Lo, IFM; Lam, STS; Shek, CC; Tiu, SC; Tong, SF | 2005 | 94 |
| Serum adiponectin is reduced in acromegaly and normalized after correction of growth hormone excess | Lam, KSL; Xu, A; Tan, KCB; Wong, LC; Tiu, SC; Tam, S | 2004 | 114 |
 | Serum adiponectin is reduced in acromegaly and normalized after correction of growth hormone excess | Lee, KK; Xu, A; Tan, KCB; Wong, LC; Tiu, SC; Tam, SCF; Lam, KSL | 2004 | 81 |
| Genetic and clinical characteristics of maturity-onset diabetes of the young in Chinese patient | Xu, J; Dan, Q; Chan, VNY; Wat, NMS; Tam, S; Tiu, SC; Lee, KF; Siu, SC; Tsang, MW; Fung, LM; Chan, KW; Lam, KSL | 2004 | 93 |
 | A study on the effect of testosterone replacement on the development of obstructive sleep apnoea (OSA) | Lam, B; Chow, MS; Choi, KL; Ooi, CGC; Tiu, SC; Lam, KSL; Ip, MSM | 2003 | 266 |
| Multiple endocrine neoplasia type 2 in Chinese families | Lo, CY; Wat, NMS; Lam, KY; Tiu, SC; Chan, JKY; Lam, KSL | 2003 | 112 |
| Multiple endocrine neoplasia type 1 (MEN 1): genetic and clinical analysis in Southern Chinese | Tso, AWK; Rong, R; Lo, CY; Tan, KCB; Tiu, SC; Wat, NMS; Xu, J; Villablanca, A; Larsson, C; Teh, BT; Lam, KSL | 2003 | 84 |
| Effects of treatment with Sandostatin LAR on lipoprotein metabolism in patients with acromegaly | Tan, KCB; Pang, WC; Tiu, SC; Lam, KSL | 2003 | 93 |
| Multiple endocrine neoplasia type 2A in Chinese families (Letter to the Editor) | Lo, CY; Wat, NMS; Lam, KY; Tiu, SC; Chan, J; Lam, KSL | 2003 | 98 |
| The clinical genetics of multiple endocrine neoplasia type 1 in Chinese | Rong, R; Tso, AWK; Lo, CY; Tan, KCB; Tiu, SC; Wat, NMS; Xu, JY; Teh, BT; Lam, KSL | 2003 | 200 |
| Multiple endocrine neoplasia type 1 (MEN1): Genetic and clinical analysis in the Southern Chinese | Tso, AWK; Rong, R; Lo, CY; Tan, KCB; Tiu, SC; Wat, NMS; Xu, JY; Villablanca, A; Larsson, C; Teh, BT; Lam, KSL | 2003 | 64 |
| Effects of treatment with Sandostatin® LAP® on small dense LDL and remnant-like lipoproteins in patients with acromegaly | Tan, KCB; Pang, RWC; Tiu, SC; Lam, KSL | 2003 | 55 |
| Multiple endocrine neoplasia type 2A in Chinese families | Lo, CY; Wat, NMS; Lam, KY; Tiu, SC; Chan, J; Lam, KSL | 2003 | 36 |
| Effects of treatment of acromegaly with Sandostatin® LAR® on lipolytic enzymes and cholesteryl ester transfer protein activities | Lee, KK; Tan, KCB; Pang, RWC; Tiu, SC; Lam, KSL | 2001 | 254 |
| Novel mutation and polymorphisms of the HMBS gene detected by denaturing HPLC | Lam, CW; Poon, PMK; Tong, SF; Lo, AWI; Lai, CK; Choi, KL; Tiu, SC; Chan, YW; Shek, CC | 2001 | 48 |
| Acarbose in NIDDM patients with poor control on conventional oral agents: A 24-week placebo-controlled study | Lam, KSL; Tiu, SC; Tsang, MW; Ip, TP; Tam, SCF | 1998 | 356 |
| An open multicentre study evaluating the use of Novopenr3 for insulin requiring diabetic patients. | So, TMY; Jorgensen, LN; Lam, KSL; Cockram, CS; Cheung, KO; Lau, IT; Lo, KW; Siu, SC; Tiu, SC; Tsang, MW | 1996 | 77 |
|
